Skip to main content

EW Healthcare Partners, L.P.'s Form 4/A amendment

Amended

EyePoint, Inc.EYPT · filed Aug 30, 2023

Accession no.
0000899243-23-018606
Filed
Aug 30, 2023, 5:32 PM ET
Trade date
Aug 24-25, 2023
Filing delay
6 days
Rule 10b5-1 plan
Not checked
Original filed
Aug 28, 2023

This filing lists 4 non-derivative transactions. Open-market sales total $2.49M. It was filed 6 days after the trade.

This amendment replaces 0000950170-23-044843 (filed Aug 28, 2023).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
EW Healthcare Partners, L.P.CIK 000161234310% Owner, Other: See footnotes 1 and 6
Essex Woodlands Fund IX-GP, L.P.CIK 000165228510% Owner
Essex Woodlands IX, LLCCIK 000165228610% Owner
EW Healthcare Partners-A, L.P.CIK 000173624010% Owner, Other: See footnotes 1 and 6

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 24, 2023Common Stock, $0.001 par valueSSaleDisposed−87,100$11.54F2,F7−$1,005,1343,935,940Indirect
Aug 24, 2023Common Stock, $0.001 par valueSSaleDisposed−52,180$10.56F3,F7−$551,020.83,883,760Indirect
Aug 25, 2023Common Stock, $0.001 par valueSSaleDisposed−72,925$11.09F4,F7−$808,738.253,810,835Indirect
Aug 25, 2023Common Stock, $0.001 par valueSSaleDisposed−11,731$10.45F5,F7−$122,588.953,799,104Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 133,890 shares and 81,380 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively, and EWHP-A sold 5,390 shares and 3,276 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively. EWHP now holds a total of 3,652,177 shares of Common Stock of the Issuer and EWHP-A now holds a total of 146,927 shares of Common Stock of the Issuer.

F2

Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $11.05 to $12.04. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $10.11 to $11.04. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $10.5001 to $11.50. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $10.36 to $10.50. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F6

Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

F7

This Amended Form 4 is being filed to correct an administrative error in reporting the weighted average prices at which shares were sold on August 24, 2023 and August 25, 2023 from that reported in the original Form 4 to the prices shown in this Amended Form 4.

Referenced by the price of 4 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)